Search Results 1061-1070 of 4643 for Incineration

  1. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  2. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  3. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  4. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  5. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  6. Oncology (Medical) - Clinical trials

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

  8. Publications - Ingrid J. Pritchard, M.D., M.S. - Mayo Clinic

    Maniaci MJ, Torres-Guzman RA, Avila FR, Maita K, Garcia JP, Forte AJ, Rutledge R, Dugani SB, Campbell SM, Pritchard IJ, Paulson MR.

  9. Cirrhosis - Doctors and departments - Mayo Clinic

    Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...

  10. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...